Sernova’s innovative Cell Pouch implants insulin-producing cells, and early trials have helped some people achieve full insulin independence for years. But challenges like immunosuppressants and scalability remain. In this episode, I’m joined by Jonathan Rigby, CEO of Sernova and a fellow T1D, to discuss how this technology works, the life-changing results from clinical trials, and the next steps in diabetes cure research. We explore stem cell-derived islet cells, gene-edited cells that could eliminate the need for immunosuppressants, and Sernova’s long-term vision for making a functional cure accessible.

DISCLAIMERS: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.

*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Sernova's Type 1 Diabetes Cure Explained